Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 20.43
-0.31 (-1.49%)
May 20, 2026, 11:15 AM CST
SHE:002262 Revenue
Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.61B CNY in the quarter ending March 31, 2026, with 6.58% growth. This brings the company's revenue in the last twelve months to 6.01B, up 2.73% year-over-year. In the year 2025, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.91B with 3.75% growth.
Revenue (ttm)
6.01B
Revenue Growth
+2.73%
P/S Ratio
3.51
Revenue / Employee
1.00M
Employees
6,003
Market Cap
21.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.91B | 213.56M | 3.75% |
| Dec 31, 2024 | 5.70B | 656.13M | 13.01% |
| Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
| Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
| Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apeloa Pharmaceutical Co.,Ltd | 9.50B |
| Tasly Pharmaceutical Group | 8.35B |
| Kangmei Pharmaceutical | 5.03B |
| Chengdu Kanghong Pharmaceutical Group | 4.43B |
| Betta Pharmaceuticals | 3.73B |
| Guangdong Zhongsheng Pharmaceutical | 2.51B |
| Walvax Biotechnology | 2.40B |
| Jilin Aodong Pharmaceutical Group | 2.23B |
Jiangsu Nhwa Pharmaceutical Co., LTD News
- 4 weeks ago - Jiangsu Nhwa Pharmaceutical Co., LTD Annual report: H2 2025 - Filings
- 4 weeks ago - Jiangsu Nhwa Pharmaceutical Co., LTD Quarterly report: Q1 2026 - Filings
- 5 months ago - Luye Pharma Grants Nhwa Rights To Commercialize Three LAI Antipsychotics In Chinese Mainland - Nasdaq
- 7 months ago - Jiangsu Nhwa Pharmaceutical Co., LTD Quarterly report: Q3 2025 - Filings
- 10 months ago - Jiangsu Nhwa Pharmaceutical Co., LTD Quarterly report: H1 2025 - Filings